Nope, I totally disagree! This is not a pump and
Post# of 36537
(Total Views: 331)
Posted On: 01/15/2021 4:08:51 PM
Nope, I totally disagree!
This is not a pump and dump. I am sure that there actually is a whole lot of substance behind all of this, it is just not marketed in an appropriate way.
To me this the result of a missing real IR/PR strategy.
There is no concept behind all this, where every PR is strategically published at the right time to establish momentum and then keep it going, with promises made, and kept as promised. And follow ups placed in a well ochestrated fashion.
Right now, it seems to be nothing much more than "Oops, there is something new, I think it worth spitting out to the public", timing is not planned (as we've seen on new year's eve), not enough thought is given to the wording and even less to the headlines (as for the last PR, where they announce the CC in the headline, and then mentioned the $500 million valuation somewhere after a lengthy text, where only the dedicated reader would find it, instead of headlining the news such as
LAST MISSING PIECE FOR IPO RECEIVED; NGIO's INDEPENDENT VALUATION REVEALED $500 MILLION; CC TO DISCUSS ROAD TO IPO COMING UP
Now that would have drawn more attention to this PR, right?
What would have been required is additional ammunition to be ready as follow up to this PR from last friday. I would have liked to see a sequence such as the following:
Friday: Last missing piece for IPO received ==> $500 Million
Tuesday: key factors for IPO determined ==> IP offering share price $4, outstanding shares will be 250 Mill.
Thursday: The date for the IPO has been set with the SEC and NASDAQ officials to be 2/18/2021
Monday: $5 Million from Chinese partner's received, and knowledge transfer started.
Wednesday: IND application for "The Complete Vaccine" clinical trials handed in to the FDA.
... continue in this manner, maybe reduced to 1 PR/week after that, until the CC date
That is what would have sparked real excitement among old and potential new investors. One has to keep the momentum going for them, especially if one is aware of the negative environment for one's stock being traded on the OTC.
C'mon Joe, C'mon Todd, you can do better than what you've been doing so far.
This is not a pump and dump. I am sure that there actually is a whole lot of substance behind all of this, it is just not marketed in an appropriate way.
To me this the result of a missing real IR/PR strategy.
There is no concept behind all this, where every PR is strategically published at the right time to establish momentum and then keep it going, with promises made, and kept as promised. And follow ups placed in a well ochestrated fashion.
Right now, it seems to be nothing much more than "Oops, there is something new, I think it worth spitting out to the public", timing is not planned (as we've seen on new year's eve), not enough thought is given to the wording and even less to the headlines (as for the last PR, where they announce the CC in the headline, and then mentioned the $500 million valuation somewhere after a lengthy text, where only the dedicated reader would find it, instead of headlining the news such as
LAST MISSING PIECE FOR IPO RECEIVED; NGIO's INDEPENDENT VALUATION REVEALED $500 MILLION; CC TO DISCUSS ROAD TO IPO COMING UP
Now that would have drawn more attention to this PR, right?
What would have been required is additional ammunition to be ready as follow up to this PR from last friday. I would have liked to see a sequence such as the following:
Friday: Last missing piece for IPO received ==> $500 Million
Tuesday: key factors for IPO determined ==> IP offering share price $4, outstanding shares will be 250 Mill.
Thursday: The date for the IPO has been set with the SEC and NASDAQ officials to be 2/18/2021
Monday: $5 Million from Chinese partner's received, and knowledge transfer started.
Wednesday: IND application for "The Complete Vaccine" clinical trials handed in to the FDA.
... continue in this manner, maybe reduced to 1 PR/week after that, until the CC date
That is what would have sparked real excitement among old and potential new investors. One has to keep the momentum going for them, especially if one is aware of the negative environment for one's stock being traded on the OTC.
C'mon Joe, C'mon Todd, you can do better than what you've been doing so far.
(6)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼